Barbara Emilia Nikitiuk

No ORCID on file · 3 papers in corpus
observational 2026
Could Serum CA125 Aid the Clinical Assessment of Volume Status of End-Stage Kidney Disease Patients Treated by Peritoneal Dialysis Patients?
Blood purification ·doi:10.1159/000553236

INTRODUCTION: Volume overload is a major cause of technique failure, morbidity and mortality for peritoneal dialysis patients (PD). Biomarkers could potentially aid the clinical assessment of patients. Recently, Cancer antigen 125 (CA125) h…

meta-analysis 2024
On Whether Ca-125 Is the Answer for Diagnosing Overhydration, Particularly in End-Stage Kidney Disease Patients-A Systematic Review
International journal of molecular sciences ·doi:10.3390/ijms25042192

Overhydration (OH) is a prevalent medical problem that occurs in patients with kidney failure, but a specific marker has still not been found. Patients requiring kidney replacement therapy suffer from a water imbalance, which is correlated …

review 2022
Using adipose-derived mesenchymal stem cells to fight the metabolic complications of obesity: Where do we stand?
Obesity reviews : an official journal of the International Association for the Study of Obesity ·doi:10.1111/obr.13413

Obesity is a critical risk factor for the development of metabolic diseases, and its prevalence is increasing worldwide. Stem cell-based therapies have become a promising tool for therapeutic intervention. Among them are adipose-derived mes…